This week, in his radio programme “On va vers le beau“, Jonas Schneiter meets people who are working for sustainable solutions by developing different projects related to the production and transformation of hemp in Switzerland. Whether it is in the production of CBD, medicines, fashion or construction, he questions the role, the possibilities and the importance of hemp in an ecological transition process. Today, it is Cédric Heeb, founder and director of PhytoXtract SA and Christophe-Georges Christophi, head pharmacist of the Florissant Pharmacy. These are two members of the network, the Pharmacy “Florissant” and the Manufacturer “PhytoXtract SA”, who took part in this radio programme in the facilities of cannaxtract labs.
Visit the new educational event Cannabis as medicine – «From plant to patient». Implementation: 01.05.2021 – 30.06.2021 (on demand until 31.12.2021) Type: e-learning + online workshop (05.06.2021) Costs: CHF 350 Accreditations (among others): FPH: 100, accredited for continuing education FPH Offizin (role 1.2) and continuing education. SDV: requested SGAIM: 4 points for workshop + up…
Bern, 25.08.2021 – At its meeting on August 25, 2021, the Federal Council opened the consultation on the implementation of the amendment to the Narcotics Act (BetmG) passed by Parliament. The amendment is intended to facilitate access to treatments with therapeutic cannabis. In the future, a prescription will no longer require the granting of an exceptional authorization from the Federal Office of Public Health (FOPH). Cannabis for consumption purposes, on the other hand, will continue to be prohibited.
In future, such prescriptions will no longer require exceptional authorisation from the Federal Office of Public Health (FOPH).
Bern, December 9th 2020. There is two good news for those who use #cannabis to relieve chronic pain and muscle spasms.
Trends and Developments The current regulatory environment surrounding cannabinoid-based products in Switzerland is unfortunately still marked by a high degree of uncertainty, due both to vague legislative requirements and heterogenous, sometimes arbitrary, enforcement. However, with the rise of public awareness of the general benefits of the cannabis plant as a result of the cannabidiol (CBD)…